Viewing StudyNCT00391066



Ignite Creation Date: 2024-05-05 @ 5:07 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00391066
Status: TERMINATED
Last Update Posted: 2015-10-02
First Post: 2006-10-19

Brief Title: Lumiliximab With Fludarabine Cyclophosphamide and Rituximab FCR Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia CLL
Sponsor: Biogen
Organization: Biogen

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-11
Start Date Type: None
Primary Completion Date: 2010-07
Primary Completion Date Type: ACTUAL
Completion Date: 2010-12
Completion Date Type: ACTUAL
First Submit Date: 2006-10-19
First Submit QC Date: October 19 2006
Study First Post Date: 2006-10-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2015-09-17
Disp First Submit QC Date: September 17 2015
Disp First Post Date: 2015-10-02
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2015-09-17
Last Update Post Date: 2015-10-02
Last Update Post Date Type: ESTIMATED